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SUMMARY
Objective: To identify preoperative and transoperative risks factors for postoperative 
complications developed in lung resection surgery. Methods: During 14 months; 189 
patients underwent pulmonary resection and were enrolled to the study. After a clini-
cal interview, patients were evaluated by laboratory, pulmonary function tests and ra-
diography, submitted to a surgical procedure, and were followed during their stay in 
the ICU and hospital, evaluating postoperatory complications and death. Results: 
The postoperative rate of complications was 52.9%: respiratory (34.3%), infectious 
(31%), and cardiovascular (21.4%). Respiratory complications were related to smok-
ing (p  <  0.01, RR 2.31), airway obstruction by spirometry (p  =  0.01, RR 2.60), pres-
ence of anemia (p < 0.01, RR 2.13), and prolonged protrombine time [PT] (p = 0.03, 
RR 1.77). Infection complications were related to smoking (p  <  0.01, RR 2.69), 
airway obstruction by spirometry (p = 0.01, RR 3.31), presence of anemia (p < 0.01, RR 2.10), 
and prolonged PT (p = 0.03, RR 2.29). Cardiovascular problems were related with older age 
(p < 0.01, RR 2.66), cigarette smoking (p < 0.01, RR 4.55), and hypoxemia (p = 0.03, RR 2.43). 
The postoperative mortality rate was 7.1%. Conclusion: A preoperative evaluation can 
provide a suitable and safe postoperative prediction of complications in patients submit-
ted to lung resection. Patients with COPD, hypoxemic, older, and anemic patients must 
be classified as high-risk for developing these complications.
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INTRODUCTION
Benefits of pulmonary surgical treatment are well-estab-
lished. Life expectation of patients with non-small cell 
lung cancer is increased to 48 months, compared to 17 
months of survival of patients submitted only to medical 
treatment1. Furthermore, surgery for bronchiectasis in-
creases the quality of life2 and survival of these patients3. 
However, postoperative complications are a significant 
cause of morbidity and mortality in patients submitted to 
thoracic or abdominal surgeries4.
Managing of these patients requires an understanding 
of the predictable changes in pulmonary physiology oc-
curring with surgery and anesthesia as well as a knowledge 
of factors associated with development of postsurgical 
complications. The surgical procedure causes reduction of 
lung capacity (represented by forced vital capacity [FVC] 
and forced expiratory volume in one second [FEV1]) dia-
phragm dysfunction, impairs gas exchange, and cough and 
mucociliary clearance leading to development of micro-
atelectasis and postoperative hypoxemia4,5. These modifi-
cations are exacerbated in chronic obstructive pulmonary 
disease [COPD]6,7, as well as in older patients8, survivors of 
recent myocardial infarction9, in starvation10 and smoking 
patients11.
The patients submitted to pulmonary resection proce-
dures developed severe and frequent postoperative com-
plications, so these patients frequently are submitted to the 
preoperative risk evaluation12. Advances in surgical and 
anesthetic techniques, combined with a detailed preop-
erative and sophisticated perioperative assessment, have 
contributed to an increasing number of adults undergoing 
these procedures12-14.
The objective of this study was to identify preoperative, 
and transoperative risks factors for developed postopera-
tive complications in lung resection surgery.
METHODS
PATIENT MANAGEMENT
All patients submitted to lung surgery at a reference for 
clinical and surgical lung diseases hospital over a 14 month 
period were prospectively studied. All subjects enrolled 
underwent elective lung resection surgeries (lobectomy 
and pneumonectomy) with or without chest wall resec-
tion due to cancer, abscesses, or bronchiectasies. Exclu-
sion criteria were: < 18 years of age, palliative resection, 
lung transplantation, thoracic trauma, thoracic surgery 
with no lung resection, thoracoscopy or thoracotomy for 
lung nodule biopsy, tracheostomy, emergency surgery, 
and informed consent declined. The study was approved 
by the Ethics in Research Committee of both hospitals 
and Informed Consent was obtained from all patients or 
next of kin.
The preoperative evaluation included a complete his-
tory, physical examination, blood cell count, biochemical 
profile, chest film, 12-lead ECG, and pulmonary function 
tests. When FEV1 was < 60% of the predicted value, a dif-
ferential lung perfusion scan was performed. Patients with 
borderline spirometric results or impaired exercise toler-
ance underwent a cardiopulmonary exercise test on a bi-
cycle ergometer. Transthoracic echocardiography, thalli-
um-dipyridamole myocardial scintigraphy, or coronary 
angiogram were performed in patients with risk factors 
for coronary artery disease [CAD] and in those patients 
with low functional capacity, according to guidelines pub-
lished by the American College of Physicians [ACP]15,16. 
Preoperatively, as routine a thoracic epidural catheter was 
inserted, except for patients who refused placement of the 
catheter, patients with coagulation disorders, acute neu-
rologic problems, local or systemic infections, or techni-
cal failures (i.e., catheter malpositioning or malfunction). 
Prophylactic antibiotic therapy (i.e., cefuroxime, 1.5 g ev-
ery 8 h for 24 h) was administered routinely. All patients 
were operated by one of three specialized surgeons in tho-
racic surgeries and were managed by the same team of an-
esthesiologists and chest critical care physicians.
After surgery, patients were monitored for at least 
48 h in the postanesthesia care unit or intensive care unit 
[ICU] to provide intensive nursing and respiratory care 
with emphasis on pain control, diaphragmatic breathing, 
aggressive pulmonary toilet by aggressive postoperative 
physical therapy, as well as early mobilization, ambulation, 
and feeding. Intravenous [IV] uid infusion was limited 
to compensate for volume of blood loss with 0.9% saline 
solution and to replace evaporation loss with 5% glucose 
in saline solution at a rate of 1 mL/kg/h. Postoperative pain 
was assessed at rest and during coughing with a visual ana-
log scale. The analgesic regimen was titrated to keep the 
visual analog scale at <  4/10 using either IV (morphine 
sulfate and nonsteroidal anti-inammatory drugs) or epi-
dural catheter (morphine sulfate) from 2 to 4 days.
DATA COLLECTION AND EXTRACTION
The preoperative data registered during standard interview 
and physical exam included: age, gender, smoking history 
(positive when smoking more than 20 pack years), pres-
ence of concomitant diseases (diabetes, cardiovascular, re-
nal, and pulmonary disease). Other preoperative data reg-
istered were: arterial blood gases on air, blood cell count, 
biochemical profile, pulmonary function test [PFT](FEV1 
and FVC as percentage of predicted), 12-lead ECG, type of 
malignancy, and informed consent. Diagnosis of chronic 
obstrutive pulmonary disease [COPD] was based on a his-
tory of myocardial infarction or angina, or typical Q waves 
seen on the ECG. Elevated blood pressure, arrhythmias, 
and diabetes mellitus requiring medication were considered 
significant comorbidities. Peripheral artery disease was de-
fined by clinical evidence (i.e., claudication at exercise and 
past or current vascular surgery) or arteriography. Diagno-
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sis of COPD was based on criteria of the American Thoracic 
Society [ATS] and on results of pulmonary functional tests 
(i.e., FEV1/FVC,  70% of predicted value)17. Specific cut-
o points were selected to define risk factors: (a) advanced 
age:   65 years; (b) moderate to severe COPD: FVC or 
FEV1  60% of the predicted; (c) hypoxemia in room air: 
PaO2  60 mmHg; (d) hypercapnia: PaCO2    45 mmHg; 
(e) lymphocytopenia: lymphocyte count < 1500/L; (f) in-
creased hemorrhage risk: prothrombin time [PT] > 13 sec; 
and (g) anemia: hemoglobin  10 g/dL.
Intraoperative risk factors studied were perioperative 
estimated blood loss (3 or more packed red blood cells re-
quirement), and occurrence of a hemodynamic instabil-
ity defined as need for IV vasopressor or IV vasodilator 
during procedure. Experience of the surgeon and anesthe-
tist were not recorded since all surgical procedures were 
performed by the same surgical and anesthesia team with 
more than 20 years of experience in management of lung 
diseases. The duration of the surgical procedure (from skin 
incision to closure) was not registered.
Patients were followed during ICU and hospital stay to 
evaluate postoperative complications and mortality. Com-
plications were grouped as (a) respiratory: atelectasis, en-
dotracheal reintubation, mechanical ventilation require-
ment >  24  h, and pleural air leak for more than 7 days; 
(b) cardiovascular: arrhythmias, hemodynamic instability 
with need for inotropic or vasodilators and coronary acute 
syndrome; (c) infectious: pneumonia (defined as new and 
persistent lung infiltrates at chest film, axillary tempera-
ture > 38.5°C, and macroscopically proven purulent tra-
cheal secretions), wound infection and pleural empyema; 
(d) metabolic: hyperglycemia (need of continuous insu-
lin), eletrolite disturbances, and acute renal insu ciency 
(need of dyalisis); and (e) prognosis (survival or death). 
Severe postoperative complications were considered: en-
dotracheal reintubation, hemodynamic instability with 
need for inotropic or vasodilators, coronary acute syn-
drome, pneumonia, pleural empyema, acute renal insuf-
ficiency, and death. Each patient could have one or more 
complications therefore, the number of complications was 
greater than the number of patients. Operative mortality 
was defined as death until 30th day after procedure.
Data were classified as preoperative, and intraopera-
tive, risk factors and as postoperative complications.
STATISTICAL ANALYSIS
Data were analyzed using statistical software (Epi-Info 
version 6.0). Univariate analysis was carried out using the 
2 test or Fisher’s Exact Test for categorical variables and 
the Wilcoxon or Kruskal-Wallis test for continuous vari-
ables. Multivariate analysis (multiple logistic regression) 
was used to determine the relative risk (RR) and odds 
ratio (OR) and their 95% confidence intervals (95%CI) 
in variables with a p value <0.05 in univariate analysis 
for postoperative complications and death. All tests were 
two sided, and p values of < 0.05 were considered statisti-
cally significant.
RESULTS
STUDY POPULATION
During the 14 months reference period, 532 thoracic sur-
geries were performed, and 189 patients were prospective-
ly enrolled, and submitted to elective lung resection sur-
gery (lung lobectomy and pneumonectomy). Sixty-nine 
point three percent were male, mean age of 62.2  ±  12.4 
years, and 104 smokers (mean cigarette consumption was 
49 pack years). More men than women were smoking 
(92.1% and 53%, respectively). Lung cancer was present 
in 75.5% of the cases. Preoperative clinical characteristics 
of patients, laboratory data and type of surgery as well as 
intraoperatory data are presented in Table 1. 
Table 1 – Preoperative characteristics, type of surgery, 
transoperatory data, and postoperative complications
Characteristics n (%)
Preoperative characteristics
Clinical data
Age ≥ 65 yr
Male gender
Cigarette smokers
Spirometry data
FVC ≤ 60%
FEV1 ≤ 60%
Arterial blood gases
PaO2 ≤ 60mmHg
PaCO2 ≥ 45mmHg
Laboratory analysis
Lymphocytopenia
Prolonged prothrombin time
Anemia
49 (25.9)
131 (69.3)
132 (69.8)
84 (44.4)
98 (51.8)
93 (49.2)
16 (8.4)
44 (22.2)
39 (20.6)
82 (43.3)
Type of surgery
Lobectomy
Pneumonectomy
140 (74.1)
49 (25.9)
Complications
Respiratory
Atelectasis
Endotracheal reintubation*
Mechanical ventilation > 24 h
Pleural air leak  > 7 days
Cardiovascular
Arrhythmias
Hemodynamic instability*
Acute coronary syndrome*
Infectious
Pneumonia*
Wound infection
Pleural empyema*
Metabolic
48 (34.3)
16 (11.5)
13 (9.4)
20 (14.2)
11 (7.8)
30 (21.4)
24 (17.5)
46 (34.5)
1 (0.7)
42 (31)
41 (29.7)
15 (10.7)
12 (8.6)
2 (1.4)
* Considered severe postoperatory complications
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POSTOPERATIVE COMPLICATIONS
Postoperative complications are presented in Table  1. 
The postoperative rate of complications was 52.9%: respi-
ratory (34.3%), infectious (31%), cardiovascular (21.4%), 
and metabolic (1.4%). The mortality rate was 13.7%, and 
mostly due to sepsis (52.9%) follow pneumonia (29.7%) or 
pleural empyema (8.6%).
Respiratory postoperative complications were related 
with smoking (p < 0.01, RR 2.31 [95% CI 1.92 - 2.95]), air-
way obstruction in spirometry (p = 0.01, RR 2.6 [95% CI 
1.8 - 3.1]), presence of anemia (p < 0.01, RR 2.13 [95% CI 
1.12 - 3.92]), and prolonged PT (p = 0.03, RR 1.77 [95% CI 
0.94  -  4.16]). Delay in extubation was the only respira-
tory complication that correlated individually with the 
cigarette smoking risk factor (p  =  0.02, RR 2.76 [95%CI 
1.53 - 3.38]). Table 2 shows the relationship between post-
operative complications and preoperative characteristics, 
type of surgery, and intraoperative data.
Infectious postoperative complications were related 
with smoking (p  <  0.01, RR 2.69 [95%  CI 1.28  -  3.54]), 
airway obstruction in spirometry (p  =  0.01, RR 3.31 
[95% CI 2.56  - 3.85]), presence of anemia (p < 0.01, RR 
2.10 [95% CI 1.25  - 3.12]), and prolonged PT (p = 0.03, 
RR 2.29 [95% CI 1.82 - 3.17). Pneumonia was the only in-
fectious complication correlated with smoking (p < 0.01, 
RR 2.69 [95% CI 2.42 - 2.98]), airway obstruction in spi-
rometry (p < 0.01, RR 3.31 [95% CI 2.96 - 3.77]), presence 
of anemia (p < 0.01, RR 2.12 [95% CI 1.37  - 3.75]), and 
prolonged PT (p < 0.01, RR 2.26 [95% CI 0.76 - 5.78]). Pre 
and intraoperative risk factors were unable to predict oc-
currence of wound infection or pleural empyema.
Cardiovascular problems were related with older age 
(p < 0.01, RR 2.66 [95% CI 2.21 - 2.96]), cigarette smoking 
(p < 0.01, RR 4.55 [95% CI 3.65 - 5.95]), and hypoxemia 
(p = 0.03, RR 2.43 [95% CI 1.02 - 3.68]).
Metabolic postoperative problems were not predicted 
by the presence of pre or intraoperative risks. Pneumonec-
tomies did not present more postsurgical complications 
when compared with lobectomies. When evaluating ar-
terial blood gases, hypercapnia did not relate with com-
plications. Detailed analysis of preoperative ECG did not 
predict risk of surgical complications. It is important to re-
member that patients could have one or more postsurgical 
complications.
POSTOPERATIVE MORTALITY
Smoking (p = 0.01, RR 3.76 [95% CI 2.54 - 5.02]) and hy-
poxemia (p = 0.02, RR 3.56 [95% CI 3.08 - 3.97]) were the 
preoperative risk factors that increased patient postop-
erative mortality. Although requirement for intraoperative 
blood transfusion did no increase postoperative compli-
cations individually, it increased postoperative mortality 
(p = 0.01, RR 4.53 [95% CI 1.72 - 7.65]), as well as the need 
of pneumonectomy (p < 0.01, RR 2.31 [95% CI 1.22 - 4.19]).
Table 3 shows the increase of mortality due to finding 
of postsurgical complications.
DISCUSSION
Thoracic surgeries are procedures associated with rela-
tively high rates of postsurgical complications18. Incidence 
of pulmonary complications is uncertain, due to the vari-
ability of definitions used by dierent authors19. Although 
physicians involved in preoperative evaluations can base 
surgical risk assessment on extensive research, their ability 
to do so correctly is limited by methodological problems 
in literature such as poor standardization and definition 
of postoperative complications, inadequate blinding of ob-
servers, selection bias, limitation by study size, and report-
ing of non-clinical significant complications (e.g., micro-
atelectasis)20.
Table 2 – Univariate analysis of potential risk factors for operative risk factors*
Risk factors
Postsurgical complications
Respiratory Cardiovascular Infectious Metabolic
Age ≥ 65-years ns < 0.01 ns ns
Male gender ns ns ns ns
Smoking < 0.01 < 0.01 < 0.01 ns
COPD moderate-severe 0.01 ns 0.01 ns
PaO2 ≤ 60mmHg     ns 0.03 ns ns
PaCO2 ≥ 45mmHg ns ns ns ns
Lymphocytopenia ns ns ns ns
Prolonged prothrombin time 0.03 ns 0.03 ns
Anemia < 0.01 ns < 0.01 ns
Pneumonectomy ns ns ns ns
Requirement of  3 packed red blood cells or more ns ns ns ns
*All data are represented with p value if statistically significant. ns, not significant (p value ≥ 0.05);  COPD, chronic obstructive pulmonary 
disease
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PATIENT-RELATED RISK FACTORS
Age. Some authors consider advanced age as a risk factor 
for mortality and perioperative complications8,21-24, others 
disagree with it25-30. Ergina et al.31 demonstrated that older 
patients have more respiratory or cardiovascular complica-
tions, and Tisi et al.7 suggested that it was due to the physi-
ological efiect of aging (reduction of the vital capacity, peak-
fiow, elastic lung retraction, and increase of residual lung 
volume). Despite early suggestions of an increased risk of 
pulmonary complications with advanced age, this is not an 
independent risk factor for pulmonary complications. The 
healthy status of a patient, mainly cardiorespiratory seems 
to be much more important than age26. In our study, those 
older 65 years had no increase of postoperative mortality, 
and in agreement with Kroenke et al.23, we observed an as-
sociation with cardiovascular complications.
Smoking. The beneficial efiects of smoking cessation, 
including improvement in ciliary and small airway func-
tion and a decrease in sputum production, occur gradually 
over several weeks. The risk is highest in patients who were 
smoking within the last 2 months, and patients who had 
quit smoking for more than 6 months, have a risk simi-
lar to those who do not smoke. Postoperative morbidity 
did not decrease in patients who had quit smoking for less 
than 4 weeks32. Our study showed increase of pulmonary 
and cardiovascular complications as well as increase of 
mortality rates.
Pulmonary function tests. Results of several retrospec-
tive studies of routine preoperative PFT disclosed only a 
marginal benefit in predicting postoperative complications 
in patients except in those undergoing lung resection. PFT 
could be used to identify high-risk patients for whom ag-
gressive perioperative management is warranted. The ACP 
consensus statement15,16,33 suggests the following indications 
for preoperative PFT: (a) patients undergoing cardiac or up-
per abdominal surgery with a history of smoking or dys-
pnea; (b) patients undergoing lower abdominal surgery if 
dyspnea or history of smoking indicates prolonged surgery; 
(c) patients undergoing orthopedic surgery with uncharac-
terized lung disease; (d) patients undergoing lung resection; 
(e) older than 60 years of age; (f) positive smoking history; 
(g) presence of pulmonary disease; and (h) presence of pul-
monary symptoms. PFT results should not be the sole rea-
son to change plans necessary for surgery.
PFT remain the standard screening tests performed be-
fore pulmonary resection. It is generally agreed that a mini-
mum value of FEV1 is required preoperatively (2 L before 
pneumonectomy and 1.5  L lobectomy, respectively) and 
that further cardiopulmonary testing is needed in patients 
with marginal lung function34. Variable cut-ofi values of 
FEV1 (ranging from 35% to 80%) have been arbitrarily cho-
sen to assess the severity of COPD and to predict the risk for 
pulmonary complications, but preoperative FEV1 less than 
60% is still a main predictor of perioperative mortality and 
respiratory morbidity35.
COPD. Patients with severe COPD are 6 times more 
likely to have a major postoperative complication35. Elective 
surgery should be deferred in patients who are symptom-
atic, have poor exercise capacity, or have acute exacerbation. 
PFT results do not facilitate identification of the high-risk 
patients or of severity of dysfunction when risk of surgery 
is forbidding. Therefore, surgery should never be withheld 
based on PFT results33. Patients with severe COPD, classi-
fied as very high risk, may undergo surgery and will face 
a moderate risk of postoperative complications (29%)23,35. 
We use the Kroenke et al.23 criteria and more than 40% of 
the patients presented with severe COPD based upon spiro-
metric findings, and identifing an association between FEV1 
and respiratory, cardiovascular complications.
Arterial blood gases. A PaCO2 of more than 45 mmHg 
often occurs in persons with severe COPD and indicates 
a high risk, although it is not necessarily prohibitive for 
surgery7,36,37. Hypoxemia is not a significant predictor of 
complications36. In our study, we verify that hypoxemia 
Table 3 – Multivariate analisys of the increase of mortality due to presence of postsurgical complications and type of surgery
Postsurgical complications p value OR (95%CI)
Pneumonia < 0.01 5.20 (1.93-14.04)
Mechanical ventilation required > 24 h < 0.01 13.85 (6.85-30.18)
Arrhythmias < 0.01 7.85 (3.15-19.52)
Endotracheal reintubation need < 0.01 18.45 (7.47-45.46)
Pleural empyema < 0.01 7.06 (3.16-15.79)
Atelectasis < 0.01 4.39 (1.75-11.03)
Pleural air leak for more than 7 days < 0.01 5.02 (2.21-11.43)
Need of vasodilators < 0.01 10.42 (4.70-22.74)
Need of vasopressor < 0.01 14.67 (5.76-37.32)
≥ 3 packed red blood cells < 0.01 4.53 (2.10-9.13)
Pneumonectomy < 0.01 2.31 (1.22-4.19)
OR, odds ratio
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was associated with cardiac complications, principally oc-
currence of arrhythmias. We did not find an association 
between hypercapnia and prognosis, perhaps due to the 
small number of patients with this alteration.
Anemia. Anemia is present in 10% of patients admitted 
to general hospitals38. Hemoglobin values above of 10 g/dL 
do not significantly reduce oxygen transport and treatment 
is not required before surgery, and almost 45% of our pa-
tients had anemia, based in this criteria. Our data showed 
that anemic patients had more respiratory and infectious 
complications, probably due to nutritional deficiencies not 
identified during the preoperative evaluation.
Lymphocytopenia. This is a malnutrition marker just as 
albumin level, and malnutrition is a risk of morbidity and 
mortality in critical care and surgical patients39,40. More-
over, patients submitted to thoracic surgery, frequently 
have cancer and are smokers; predisposing factors to mal-
nutrition. Busch et al.41, in 106 patients submitted to lung 
surgery due to bronchogenic cancer, did not correlate lym-
phocytopenia with higher postoperative complications, in 
agreement with our study data.
Prothrombin time. High values of PT are a contrain-
dication for surgical procedures, due to an increase of 
hemorrhagic complications42. Our data showed increased 
respiratory complications, which in our opinion is due to 
PT being a marker of hepatic synthesis capacity and not 
because of coagulation defects43. 
INTRAOPERATIVE RISK FACTORS
Perioperative blood transfusion. Whitson et al.44 showed 
that perioperative blood transfusion was associated with 
increased postoperative complications (53.5% vs. 30.5%, 
p < 0.001). In our study, blood transfusion was associat-
ed with an increased operative mortality (3.4% vs. 1.7%, 
p = 0.005) and length of stay after surgery (median 6 vs. 5 
days, p < 0.001).
POSTOPERATIVE COMPLICATIONS
Keagy et al.45,46 reported on 369 patients, 244 had postop-
erative complications during follow-up of 30 days, mainly 
cardiovascular (41%) and pulmonary (21%). Wahi et al.28, 
in 197 pneumonectomies followed-up during 30 days, 
showed 23% of arrhythmias and prolonged MV in 9.1% 
of the cases. Ferguson et al.47, evaluating 271 patients, 
showed postoperative complications in 52% of the cases; 
and Asamura et al.48, in 267 patients submitted to thora-
cotomy, found 23.6% of arrhythmias. Our study found 
respiratory complications in 34.3% of the cases, and pneu-
monia in 29.7% of the cases. 
POSTOPERATIVE MORTALITY
Some authors34,45-47,49 described variables postoperative 
mortality rates (2.8%  -  12.6%), and the higher mortality 
rates found in patients submitted to pneumonectomies 
(7.1%  -  27.4%)28,47,49. Ginsberg et al.50, reviewed 2,220 pa-
tients submitted to thoracotomies in North-American and 
Canadian reference hospitals, and showed mortality post-
segmentectomies of 1.4%, after lobectomies of 2.9%, and af-
ter pneumonectomies of 6.7%. Our data demonstrated global 
mortality of 7.1%, and pneumonectomy mortality of 19.4%.
Strengths and limitations: We believe that the strengths 
of this paper are: (a) large sample; (b) research developed 
in a hospital specialized in respiratory diseases; and (c) 
follow-up of all patients studied. We are mindful of sev-
eral limitations related to: (a) design of the study (cohort 
study); (b) no evaluation of preoperative creatinine values 
(despite all patients have values lower than 1.5 mg/dL); (c) 
single center report; (d) no evaluation of intraoperative 
data (e.g. duration of the surgery or anesthesia, and in-
traoperative uid balance); and (e) no evaluation of stairs 
climbing test in patients with preoperative VEF1 < 2 L51.
CONCLUSION
In an era of progressive cost containment and public scru-
tiny, the wisdom of aggressive preoperative evaluations for 
all surgical candidates have been questioned. Current data 
quantify the risks and morbidities associated with the care 
of seriously ill patients with coronary artery disease and 
demonstrate the need for professional and public discus-
sions focusing on the association of a high preoperative 
risk status and the consumption of resources. A concise 
and standarized preoperative evaluation can provide a 
suitable and safe postoperative prediction of complica-
tions in patients submitted to lung resection, and patients 
with COPD, hypoxemic, older, anemic patients, and need 
of pneumonectomy must be classified as high-risk for de-
velop postoperative complications.
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